IMPROVED OUTCOME OVER TIME AFTER SECOND ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AML. AN ANALYSIS OF 1540 PATIENTS ON BEHALF OF THE ALWP OF EBMT

被引：0

作者：

Schmaelter, Ann-Kristin ^{[1
]}

Ngoya, Maud ^{[2
]}

Galimard, Jacques-Emmanuel ^{[2
]}

Bazarbachi, Ali ^{[3
]}

Finke, Juergen ^{[4
]}

Kroeger, Nicolaus ^{[5
]}

Stoelzel, Friedrich ^{[6
]}

Stelljes, Matthias ^{[7
]}

Valerius, Thomas ^{[8
]}

Tischer, Johanna ^{[9
]}

Schroeder, Thomas ^{[10
]}

Dreger, Peter ^{[11
]}

Blau, Igor-Wolfgang ^{[12
]}

Savani, Bipin ^{[13
]}

Giebel, Sebastian ^{[14
]}

Esteve, Jordi ^{[15
]}

Nagler, Arnon ^{[16
]}

Schmid, Christoph ^{[1
]}

Ciceri, Fabio ^{[17
]}

Mohty, Mohamad ^{[2
,18
]}

机构：

[1] Univ Hosp Augsburg, Augsburg, Germany

[2] EBMT Paris Study Off, Paris, France

[3] Amer Univ, Beirut Med Ctr, Beirut, Lebanon

[4] Univ Freiburg, Freiburg, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[6] Univ Hosp Dresden, Dresden, Germany

[7] Univ Munster, Munster, Germany

[8] Univ Med Ctr Schleswig Holstein, Kiel, Germany

[9] Univ Hosp Munich, Munich, Germany

[10] Univ Hosp Essen, Essen, Germany

[11] Heidelberg Univ, Heidelberg, Germany

[12] Charite Univ Med Berlin, Berlin, Germany

[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[14] Maria Sklodowska Curie Canc Ctr & Inst Oncol, Gliwice, Poland

[15] Hosp Clin Barcelona, Barcelona, Spain

[16] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Aviv, Israel

[17] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Milan, Italy

[18] St Antoine Hosp, Paris, France

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P275

引用

页码：341 / 342

页数：2

共 50 条

[1] Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients
Schmaelter, Ann-Kristin
Ngoya, Maud
Galimard, Jacques-Emmanuel
Bazarbachi, Ali
Finke, Juergen
Kroeger, Nicolaus
Bornhaeuser, Martin
Stelljes, Matthias
Stoelzel, Friedrich
Tischer, Johanna
Schroeder, Thomas
Dreger, Peter
Blau, Igor-Wolfgang
Savani, Bipin
Giebel, Sebastian
Esteve, Jordi
Nagler, Arnon
Schmid, Christoph
Ciceri, Fabio
Mohty, Mohamad
BLOOD CANCER JOURNAL, 2024, 14 (01):
[2] Continuously Improving Outcome over Time after Second Allogeneic Stem Cell Transplantation in Relapsed Acute Myeloid Leukemia - a Retrospective Analysis of 1540 Patients on Behalf of the Acute Leukemia Working Party of EBMT
Schmaelter, Ann-Kristin
Ngoya, Maud
Finke, Juergen
Kroeger, Nicolaus
Stoelzel, Friedrich
Stelljes, Matthias
Valerius, Thomas
Tischer, Johanna
Schroeder, Thomas
Dreger, Peter
Blau, Igor Wolfgang
Savani, Bipin
Giebel, Sebastian
Esteve, Jordi
Bazarbachi, Ali
Nagler, Arnon
Schmid, Christoph
Ciceri, Fabio
Mohty, Mohamad
BLOOD, 2022, 140 : 4799 - 4801
[3] Comparison of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory AML: A study on behalf of the ALWP of EBMT
Heinicke, Thomas
Labopin, Myriam
Polge, Emmanuelle
Tischer, Johanna
Ganser, Arnold
Kroeger, Nicolaus
Brecht, Arne
Kanz, Lothar
Scheid, Christof
Dreger, Peter
Bunjes, Donald
Platzbecker, Uwe
Wagner, Eva
Savani, Bipin N.
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2019, 54 : 57 - 58
[4] Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT
Nagler, Arnon
Labopin, Myriam
Finke, Juergen
Brecht, Arne
Schanz, Urs
Niittyvuopio, Riitta
Neubauer, Andreas
Bornhaeuser, Martin
Santarone, Stella
Beelen, Dietrich
Shimoni, Avichai
Roesler, Wolf
Peric, Zinaida
Savani, Bipin N.
Giebel, Sebastian
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2019, 54 : 26 - 27
[5] Allogeneic Stem Cell Transplantation for AML Patients with RUNX1 Mutation in First Complete Remission: A Study on Behalf of the ALWP of the EBMT
Waidhauser, Johanna
Labopin, Myriam
Esteve, Jordi
Kroeger, Nicolaus
Cornelissen, Jan
Gedde-Dahl, Tobias
Van Gorkom, Gwendolyn
Finke, Juergen
Rovira, Montserrat
Schaap, Nicolaas
Petersen, Eefke
Beelen, Dietrich Wilhelm
Bunjes, Donald W.
Schmid, Christoph
Nagler, Arnon
Mohty, Mohamad
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S8 - S9
[6] Allogeneic Stem Cell Transplantation for AML Patients with Runx1 Mutation in First Complete Remission: A Study on behalf of the ALWP of the EBMT
Waidhauser, Johanna
Labopin, Myriam
Esteve, Jordi
Kroeger, Nicolaus
Cornelissen, Jan
Gedde-Dahl, Tobias
Van Gorkom, Gwendolyn
Finke, Juergen
Rovira, Montserrat
Schaap, Nicolaas
Petersen, Eefke
Beelen, Dietrich
Bunjes, Donald
Schmid, Christoph
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 181 - 182
[7] Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis
Nagler, Arnon
Ngoya, Maud
Galimard, Jacques-Emmanuel
Labopin, Myriam
Bornhaeuser, Martin
Stelljes, Matthias
Finke, Juergen
Ganser, Arnold
Einsele, Herman
Kroeger, Nicolaus
Brecht, Arne
Bethge, Wolfgang
Edinger, Matthias
Kulagin, Aleksandr
Passweg, Jakob
Blau, Igor Wolfgang
Elmaagacli, Ahmet
Schaefer-Eckart, Kerstin
Platzbecker, Uwe
Schroeder, Thomas
Bunjes, Donald
Tischer, Johanna
Martin, Sonja
Spyridonidis, Alexandros
Giebel, Sebastian
Savani, Bipin
Mohty, Mohamad
CLINICAL CANCER RESEARCH, 2022, 28 (19) : 4258 - 4266
[8] SECOND ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT2) FOR PRIMARY GRAFT FAILURE IN PATIENTS WITH ACUTE LEUKEMIA IN REMISSION: ON BEHALF OF THE ALWP OF THE EBMT
Nagler, Arnon
Labopin, Myriam
Kulagin, Aleksandr
Velardi, Andrea
Sanz, Jaime
Labussiere-Wallet, Helene
Potter, Victoria
Kuball, Jurgen
Sica, Simona
Parovichnikova, Elena
Bethge, Wolfgang
Leleu, Xavier
Platzbecker, Uwe
Stoelzel, Friedrich
Ciceri, Fabio
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 154 - 154
[9] Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia—an update on behalf of the ALWP of the EBMT
Arnon Nagler
Annalisa Ruggeri
Bone Marrow Transplantation, 2019, 54 : 713 - 718
[10] Prevalence and Outcome of CNS Relapse after Allogeneic Hematopoietic Stem Cell Transplantation In Patients Suffering from AML and all. A Study from the ALWP-EBMT
Blum, Sabine
Chalandon, Yves
Labopin, Myriam
Finke, Jurgen
Gedde-Dahl, Tobias
Ben Othman, Tarek
Cornelissen, Jan J.
Jindra, Pavel
Labussiere-Wallet, Helene
Collin, Matthew
Lenhoff, Stig
Kobbe, Guido
Caballero, Dolores
Nagler, Arnon
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 26 - 27

← 1 2 3 4 5 →